EUPRAXIA PHARMACEUTICALS REPORTS SYMPTOM RESPONSE DATA FROM ITS ONGOING PHASE 1B/2A RESOLVE TRIAL, INCLUDING NEW DATA ON ODYNOPHAGIA (PAINFUL SWALLOWING) IN EOSINOPHILIC ESOPHAGITIS PATIENTS

Reuters · 3d ago

Please log in to view news